Prevention of Iron Deficiency in 2nd Year of Life
May 24, 2007 updated by: Soroka University Medical Center
Effectiveness of Iron Supplementation in the Second Year of Life for Prevention of Iron Deficiency
Healthy babies(age 8-18 months) following a routine blood count, with no anemia or iron deficiency, will be randomly placed in two groups.
Group 1 will receive a 3 months preventive dose of an iron preparation (Ferripel 3 iron polysaccharide complex).
Group 2 will be followed up as a control group.
Following a nutritional questionnair, parents of all babies will receive instruction regarding appropriate nutrition in the 2nd year of life.
A follow-up blood count will be taken from all participating babies 3 months after recruitment.
The study aims to evaluate effectiveness of iron supplementation in the 2nd year of life.
The hypothesis is that babies who receive iron supplementation in the 2nd year of life are less likely to develop iron deficiency or anemia.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rahat, Israel
- Clalit Health Services Child Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 months to 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy babies without iron deficiency
Exclusion Criteria:
- Babies with iron deficiency or chronic diseases, premature babies and babies with hereditary hematological disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hanna Shalev, MD, Clalit Health Services
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2007
Study Registration Dates
First Submitted
May 24, 2007
First Submitted That Met QC Criteria
May 24, 2007
First Posted (Estimate)
May 25, 2007
Study Record Updates
Last Update Posted (Estimate)
May 25, 2007
Last Update Submitted That Met QC Criteria
May 24, 2007
Last Verified
May 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- sor448707ctil
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.